This video is featured in the 2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "MAST Study - Metformin in Reducing Progression Among Men on Expectant Management for Low-Risk Prostate Cancer"

183 views
June 11, 2024

Chapters

MAST Study Overview & Metformin's Role

00:00

Trial Design & Patient Demographics

01:06

Primary Outcome & Therapeutic Progression

02:57

Subgroup Analysis & Unexpected Findings

04:08

Conclusions & Future Directions

06:02

Comments 0
Login to view comments. Click here to Login